155 related articles for article (PubMed ID: 16861263)
21. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.
Wang GG; Cai L; Pasillas MP; Kamps MP
Nat Cell Biol; 2007 Jul; 9(7):804-12. PubMed ID: 17589499
[TBL] [Abstract][Full Text] [Related]
22. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.
Costello JF; Frühwald MC; Smiraglia DJ; Rush LJ; Robertson GP; Gao X; Wright FA; Feramisco JD; Peltomäki P; Lang JC; Schuller DE; Yu L; Bloomfield CD; Caligiuri MA; Yates A; Nishikawa R; Su Huang H; Petrelli NJ; Zhang X; O'Dorisio MS; Held WA; Cavenee WK; Plass C
Nat Genet; 2000 Feb; 24(2):132-8. PubMed ID: 10655057
[TBL] [Abstract][Full Text] [Related]
23. Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells.
Shen Y; Chow J; Wang Z; Fan G
Hum Mol Genet; 2006 Sep; 15(17):2623-35. PubMed ID: 16870691
[TBL] [Abstract][Full Text] [Related]
24. Analysis of histone modification around the CpG island region of the p15 gene in acute myeloblastic leukemia.
Ogawa M; Sakashita K; Zhao XY; Hayakawa A; Kubota T; Koike K
Leuk Res; 2007 May; 31(5):611-21. PubMed ID: 17074388
[TBL] [Abstract][Full Text] [Related]
25. Increased DNA methylation in the HoxA5 promoter region correlates with decreased expression of the gene during tumor promotion.
Watson RE; Curtin GM; Hellmann GM; Doolittle DJ; Goodman JI
Mol Carcinog; 2004 Sep; 41(1):54-66. PubMed ID: 15352125
[TBL] [Abstract][Full Text] [Related]
26. Microarray-based survey of CpG islands identifies concurrent hyper- and hypomethylation patterns in tissues derived from patients with breast cancer.
Piotrowski A; Benetkiewicz M; Menzel U; Díaz de Ståhl T; Mantripragada K; Grigelionis G; Buckley PG; Jankowski M; Hoffman J; Bała D; Srutek E; Laskowski R; Zegarski W; Dumanski JP
Genes Chromosomes Cancer; 2006 Jul; 45(7):656-67. PubMed ID: 16575877
[TBL] [Abstract][Full Text] [Related]
27. Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia.
Musialik E; Bujko M; Kober P; Grygorowicz MA; Libura M; Przestrzelska M; Juszczyński P; Borg K; Florek I; Jakóbczyk M; Siedlecki JA
Mol Med Rep; 2015 May; 11(5):3948-54. PubMed ID: 25585874
[TBL] [Abstract][Full Text] [Related]
28. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer.
Schlesinger Y; Straussman R; Keshet I; Farkash S; Hecht M; Zimmerman J; Eden E; Yakhini Z; Ben-Shushan E; Reubinoff BE; Bergman Y; Simon I; Cedar H
Nat Genet; 2007 Feb; 39(2):232-6. PubMed ID: 17200670
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic inactivation of HOXA5 and MSH2 gene in clear cell renal cell carcinoma.
Yoo KH; Park YK; Kim HS; Jung WW; Chang SG
Pathol Int; 2010 Oct; 60(10):661-6. PubMed ID: 20846263
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
[TBL] [Abstract][Full Text] [Related]
31. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
32. Loss of expression of HDAC-recruiting methyl-CpG-binding domain proteins in human cancer.
Müller-Tidow C; Kügler K; Diederichs S; Klümpen S; Möller M; Vogt U; Metzger R; Schneider PM; Berdel WE; Serve H
Br J Cancer; 2001 Oct; 85(8):1168-74. PubMed ID: 11710831
[TBL] [Abstract][Full Text] [Related]
33. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G
BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507
[TBL] [Abstract][Full Text] [Related]
34. Microarray analysis of tumour antigen expression in presentation acute myeloid leukaemia.
Guinn BA; Gilkes AF; Woodward E; Westwood NB; Mufti GJ; Linch D; Burnett AK; Mills KI
Biochem Biophys Res Commun; 2005 Aug; 333(3):703-13. PubMed ID: 15963951
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic regulation of microRNAs in acute lymphoblastic leukemia.
Roman-Gomez J; Agirre X; Jiménez-Velasco A; Arqueros V; Vilas-Zornoza A; Rodriguez-Otero P; Martin-Subero I; Garate L; Cordeu L; San José-Eneriz E; Martin V; Castillejo JA; Bandrés E; Calasanz MJ; Siebert R; Heiniger A; Torres A; Prosper F
J Clin Oncol; 2009 Mar; 27(8):1316-22. PubMed ID: 19164206
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic patterns at the mouse prolyl oligopeptidase gene locus suggest the CpG island in the gene body to be a novel regulator for gene expression.
Matsubara S; Takahashi T; Kimura AP
Gene; 2010 Oct; 465(1-2):17-29. PubMed ID: 20600704
[TBL] [Abstract][Full Text] [Related]
37. Control of gene expression by CpG island methylation in normal cells.
Strathdee G; Sim A; Brown R
Biochem Soc Trans; 2004 Dec; 32(Pt 6):913-5. PubMed ID: 15506922
[TBL] [Abstract][Full Text] [Related]
38. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome.
Weber M; Hellmann I; Stadler MB; Ramos L; Pääbo S; Rebhan M; Schübeler D
Nat Genet; 2007 Apr; 39(4):457-66. PubMed ID: 17334365
[TBL] [Abstract][Full Text] [Related]
39. Absence of p21(CIP 1), p27(KIP 1) and p 57(KIP 2) methylation in MDS and AML.
Brakensiek K; Länger F; Kreipe H; Lehmann U
Leuk Res; 2005 Nov; 29(11):1357-60. PubMed ID: 15936816
[TBL] [Abstract][Full Text] [Related]
40. Androgen receptor mutations are associated with altered epigenomic programming as evidenced by HOXA5 methylation.
Bens S; Ammerpohl O; Martin-Subero JI; Appari M; Richter J; Hiort O; Werner R; Riepe FG; Siebert R; Holterhus PM
Sex Dev; 2011; 5(2):70-6. PubMed ID: 21311178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
